Key Points

• Stability of vaccination coverage (VC) (against meningococcal C, MMR, hexavalent, and pneumococcal vaccines) among infants

• First estimate of meningococcal B vaccination coverage (recommended since June 2022):

  • VCO for 1 dose at 8 months is 50% for the region, a figure close to the national level.

• Human papillomavirus vaccination: Continued progress (+5 percentage points increase in 2-dose vaccination coverage among 16-year-old girls), although vaccination coverage remains insufficient:

  • Among 15-year-old girls born in 2007, 1-dose coverage is stable;

  • Among 16-year-old girls born in 2006, the two-dose vaccination coverage is increasing;

  • This trend is observed in all departments of the region;

  • Low vaccination coverage against HPV infections among young boys (13.8% for the first dose at age 15, 9.1% for the second dose at age 16) for this vaccine introduced in 2021.

• Insufficient influenza vaccination coverage (55%) among individuals with risk factors for severe influenza (compared to the 75% target):

  • Among those under 65, influenza vaccination coverage has been declining for the past two years following an increase in 2020–21;

  • Among those aged 65 and older, regional influenza vaccination coverage in 2022–23 was close to that of the previous year but lower than in 2020–21.

• Vaccination uptake among the general population has continued to rise in the Centre-Val de Loire region since 2016, reaching 86.3% (2021 Health Barometer). As a result, the region ranks among the top three regions with the highest vaccination rates.